Virus filtration is an important operation in the pharmaceutical industry, as it not only ensures if the products are adequately purified and fit for consumption, but also helps to optimize process economics and prevent loss of valuable product.
The rise in R&D expenditure, growth of biopharmaceutical industry, and increasing government support for pharmaceutical and biotechnology industry are driving factors of the virus filtration market. On the other hand stringent government regulations for validation of filtration products and highly consolidated market are the major factors restraining the growth of this market.
Browse 74 market data Tables and 104 Figures spread through 185 Pages and in-depth TOC on “Virus Filtration Market”.
http://www.marketsandmarkets.com/Market-Reports/virus-filtration-market-157281944.html
Asian region and increasing pharmaceutical outsourcing presents high-growth opportunities in this market. Growing adoption of single-use technologies is an upcoming trend in the market.
The application segment includes biologicals, medical devices, water purification, and air purification. The biologicals segment is further classified into, vaccines and therapeutics, blood and blood products, cellular and gene therapy products, tissue and tissue products and stem cell products. The end user segments included in this report are pharmaceutical & biotechnology companies, contract research organizations, academic research institutes and medical devices companies.
The geographic segments included in this report are North America, Europe, Asia, and the Rest of the World (RoW). The report maps each product segment in 10 geographic and regional segments. The North America region includes U.S. and Canada. Asian regional segment includes China, Japan, India and RoA. Geographic analysis reveals that North America accounted for the largest share of the global market in 2015. Growth in this market can be attributed to the growth of biopharmaceutical industry.
Download PDF Brochure : https://www.marketsandmarkets.com/pdfdownload.asp?id=157281944
The major players in this market include Merck KGaA (Germany), General Electric Company (U.S.), Thermo Fisher Scientific Inc. (U.S.), Lonza Group Ltd. (Switzerland), and Pall Corporation (U.S.), Charles River Laboratories International, Inc. (U.S.), Sigma-Aldrich Corporation (U.S.), Sartorius AG (Germany), Asahi Kasei Medical Co., Ltd. (Japan) and WuXi PharmaTech (Cayman) Inc. (China).
